SEI Investments
GOSS icon

SEI Investments’s Gossamer Bio GOSS Stock Holding History

SEI Investments’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-394
Closed -$10.4K – 3337
2026
Q1 		$10.4K Sell
394
-2,467
-86% -$310K ﹤0.01% 3227
2025
Q4 		$710K Buy
2,861
+2,096
+274% +$478K ﹤0.01% 2340
2025
Q3 		$161K Buy
+765
New +$135K ﹤0.01% 2658
2022
Q4 		– Sell
-463
Closed -$443K – 2597
2022
Q3 		$443K Buy
+463
New +$460K ﹤0.01% 2144

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

SEI Investments's GOSS Position: Q2 2026 in Review

SEI Investments sold out of Gossamer Bio (GOSS) in Q2 2026, closing a stake of 394 shares — an estimated $10.4K sold.

SEI Investments first reported a position in GOSS in Q3 2022 and held it in 4 quarters. The position peaked at $710K in Q4 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • SEI Investments reported no remaining Gossamer Bio position as of Q2 2026 after selling out during the quarter.
  • SEI Investments sold 394 Gossamer Bio shares in Q2 2026, an estimated $10.4K.
  • SEI Investments first reported a position in Gossamer Bio in Q3 2022 and held it in 4 quarters.
  • SEI Investments's Gossamer Bio position peaked at $710K in Q4 2025.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.